January 07, 2014
The Eighth Circuit said Tuesday that Johnson & Johnson's pharmaceutical unit must pay $630,000 to a patient who claimed the company deliberately failed to properly warn consumers of the risks linked to its antibiotic Levaquin, saying there was no misconduct that could justify overturning the award.